JPH06505992A - 抗−hiv剤としてのライサート化合物 - Google Patents
抗−hiv剤としてのライサート化合物Info
- Publication number
- JPH06505992A JPH06505992A JP4508267A JP50826792A JPH06505992A JP H06505992 A JPH06505992 A JP H06505992A JP 4508267 A JP4508267 A JP 4508267A JP 50826792 A JP50826792 A JP 50826792A JP H06505992 A JPH06505992 A JP H06505992A
- Authority
- JP
- Japan
- Prior art keywords
- hydrogen
- cyano
- dihydroquinoline
- oxo
- propenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66908291A | 1991-03-14 | 1991-03-14 | |
US669,082 | 1991-03-14 | ||
PCT/US1992/001746 WO1992016508A1 (fr) | 1991-03-14 | 1992-03-12 | Composes reissert utilises comme agents anti-hiv |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH06505992A true JPH06505992A (ja) | 1994-07-07 |
Family
ID=24684937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP4508267A Pending JPH06505992A (ja) | 1991-03-14 | 1992-03-12 | 抗−hiv剤としてのライサート化合物 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0579695A1 (fr) |
JP (1) | JPH06505992A (fr) |
AU (1) | AU1580492A (fr) |
CA (1) | CA2101335A1 (fr) |
WO (1) | WO1992016508A1 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5663169A (en) * | 1992-08-07 | 1997-09-02 | Merck & Co., Inc. | Benzoxazinones as inhibitors of HIV reverse transcriptase |
DE4428932A1 (de) * | 1994-08-16 | 1996-02-22 | Hoechst Ag | Substituierte-Chinolinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung |
US5939435A (en) * | 1997-02-03 | 1999-08-17 | American Home Products Corporation | 2-substituted-1-acyl-1,2-dihydroquinoline derivatives |
US7553967B2 (en) | 2004-03-12 | 2009-06-30 | Wyeth | 1,2-Dihydroquinoline derivatives and method for using the same to treat HIV infections |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4488989A (en) * | 1988-11-15 | 1990-06-12 | Upjohn Company, The | Phenanthrolinedicarboxylate esters, 4-aminoquinoline and isoquinoline derivatives as inhibitors of hiv reverse transcriptase |
-
1992
- 1992-03-12 CA CA002101335A patent/CA2101335A1/fr not_active Abandoned
- 1992-03-12 WO PCT/US1992/001746 patent/WO1992016508A1/fr not_active Application Discontinuation
- 1992-03-12 EP EP92908626A patent/EP0579695A1/fr not_active Withdrawn
- 1992-03-12 AU AU15804/92A patent/AU1580492A/en not_active Abandoned
- 1992-03-12 JP JP4508267A patent/JPH06505992A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP0579695A1 (fr) | 1994-01-26 |
AU1580492A (en) | 1992-10-21 |
WO1992016508A1 (fr) | 1992-10-01 |
CA2101335A1 (fr) | 1992-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6479913B2 (ja) | IRE−1αインヒビター | |
TWI406856B (zh) | 人類免疫缺乏病毒複製之抑制劑 | |
JP2568361B2 (ja) | Hiv逆転写酵素の阻害剤 | |
JP6952602B2 (ja) | ヒストンデアセチラーゼ阻害剤による白血病の治療 | |
JP2021534133A (ja) | ケトアミド系化合物およびその調製方法、医薬組成物および用途 | |
US6642224B1 (en) | Diazepan derivatives or salts thereof | |
KR102254315B1 (ko) | 글루타르이미드 유도체, 이의 용도, 이를 기반으로 한 약학 조성물 및 글루타르이미드 유도체를 생산하는 방법 | |
JPH01279866A (ja) | キノリン系メバロノラクトン類 | |
JP6918378B2 (ja) | CaMKII阻害剤及びその使用 | |
TW201412737A (zh) | 吡唑並[3,4-c]吡啶類衍生物、其製備方法及其在醫藥上的應用 | |
WO2014164667A1 (fr) | Inhibiteurs de protéases des virus west nile et de la dengue | |
JP6088639B2 (ja) | 抗マラリア薬 | |
KR20200131249A (ko) | 항-염증제, 면역조절제 및 항-증식제로서의 신규한 칼슘 염 다형체 | |
JPH02152966A (ja) | 4−ヒドロキシカルボスチリル誘導体 | |
JPWO2005079845A1 (ja) | 片頭痛予防薬 | |
KR900006118B1 (ko) | 4-퀴놀론 유도체의 제법 | |
JP3057095B2 (ja) | イサチン誘導体、その製造方法及びその使用方法 | |
JP6838045B2 (ja) | 化合物 | |
JP2004526712A (ja) | 6−フェニルベンゾナフチリジン | |
JPH06505992A (ja) | 抗−hiv剤としてのライサート化合物 | |
BE1014454A6 (nl) | Amlodipinehemimaleaat. | |
JPH0375542B2 (fr) | ||
WO2010062221A1 (fr) | Acides 2-(5-hydroxy-2-méthyl-1n-indole-3-il) acétiques substitués, leurs éthers et leur utilisation pour traiter des maladies virales | |
JPH07503002A (ja) | Nmdaアンタゴニストとしてのニトロキノロン誘導体 | |
Kluge et al. | Tricyclic aryl-substituted anticoccidial azauracils |